Keros Therapeutics (KROS)
NASDAQ:KROS
Want to see KROS full AI Analyst Report?
KROS Analyst Ratings
Moderate Buy
6 Buy
3 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
KROS Stock 12 Month Forecast
Average Price Target
$22.17
▲(89.95% Upside)
| Highest Price Target$30.00 | Average Price Target$22.17 | Lowest Price Target$16.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TD Cowen
―
Hold
―
Reiterated
03/10/26
Oppenheimer
$27
Buy
131.36%
Upside
Reiterated
03/09/26
Truist Financial
―
Buy
―
Reiterated
03/06/26
Wedbush
$16
Hold
37.10%
Upside
Reiterated
03/06/26
H.C. Wainwright
$20
Buy
71.38%
Upside
Reiterated
03/05/26
Raymond James
$23→$20
Buy
71.38%
Upside
Reiterated
03/05/26
Wells Fargo
$23→$20
Buy
71.38%
Upside
Assigned
03/05/26
William Blair
―
Hold
―
Reiterated
03/04/26
Bank of America Securities
$19→$20
Hold
71.38%
Upside
Reiterated
01/05/26
Scotiabank
$26
Buy
122.79%
Upside
Reiterated
06/10/25
Guggenheim
―
Hold
―
Reiterated
05/29/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TD Cowen
―
Hold
―
Reiterated
03/10/26
Oppenheimer
$27
Buy
131.36%
Upside
Reiterated
03/09/26
Truist Financial
―
Buy
―
Reiterated
03/06/26
Wedbush
$16
Hold
37.10%
Upside
Reiterated
03/06/26
H.C. Wainwright
$20
Buy
71.38%
Upside
Reiterated
03/05/26
Raymond James
$23→$20
Buy
71.38%
Upside
Reiterated
03/05/26
Wells Fargo
$23→$20
Buy
71.38%
Upside
Assigned
03/05/26
William Blair
―
Hold
―
Reiterated
03/04/26
Bank of America Securities
$19→$20
Hold
71.38%
Upside
Reiterated
01/05/26
Scotiabank
$26
Buy
122.79%
Upside
Reiterated
06/10/25
Guggenheim
―
Hold
―
Reiterated
05/29/25
Best Analysts Covering Keros Therapeutics
3 Months
xxx
Success Rate
9/12 ratings generated profit
Average Return
+21.22%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +21.22% per trade.
1 Year
Success Rate
9/17 ratings generated profit
Average Return
-9.04%
Copying Srikripa Devarakonda's trades and holding each position for 1 Year would result in 52.94% of your transactions generating a profit, with an average return of -9.04% per trade.
2 Years
xxx
Success Rate
7/26 ratings generated profit
Average Return
-38.59%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 26.92% of your transactions generating a profit, with an average return of -38.59% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
KROS Analyst Recommendation Trends
Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
3
2
0
6
6
Buy
3
3
1
1
1
Hold
4
5
1
4
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
10
10
2
11
10
Each month's total comprises the sum of three months' worth of ratings.
KROS Financial Forecast
KROS Stock Forecast FAQ
What is KROS’s average 12-month price target, according to analysts?
Based on analyst ratings, Keros Therapeutics’s 12-month average price target is 22.17.
What is KROS’s upside potential, based on the analysts’ average price target?
Keros Therapeutics has 89.95% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is KROS a Buy, Sell or Hold?
Keros Therapeutics has a consensus rating of Moderate Buy which is based on 6 buy ratings, 3 hold ratings and 0 sell ratings.
What is Keros Therapeutics’s price target?
The average price target for Keros Therapeutics is 22.17. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $30.00 ,the lowest forecast is $16.00. The average price target represents 89.95% Increase from the current price of $11.67.
The highest analyst price target is $30.00 ,the lowest forecast is $16.00. The average price target represents 89.95% Increase from the current price of $11.67.
What do analysts say about Keros Therapeutics?
Keros Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 9 Wall Streets Analysts.
How can I buy shares of KROS?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.